<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04365673</url>
  </required_header>
  <id_info>
    <org_study_id>TRHC_RD_LACEMRS_2020</org_study_id>
    <nct_id>NCT04365673</nct_id>
  </id_info>
  <brief_title>LACE+ and MRS Score Readmission Rate Assessment</brief_title>
  <official_title>Comparing the Predictive Strength of the LACE+ Index With the MedWise Rise Score on Hospital Readmission Rates: a Non-inferiority Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tabula Rasa HealthCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tabula Rasa HealthCare</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to demonstrate that the LACE+ score in non-inferior to the medication risk score when&#xD;
      predicting 30-day readmission post hospital discharge.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is evaluate a program that provides transition of care services&#xD;
      to a local Tucson hospital involving activities designed to reduce 30 day post hospital&#xD;
      discharge readmission rates. The organization has had a fee for service contract with this&#xD;
      hospital since 2017 to provide pharmacist delivered transition of care services. The&#xD;
      organization collects internal tracking outcome data as part of the contract deliverable and&#xD;
      is required to report it to the hospital once per month. The investigators look to assess&#xD;
      LACE+ and medication risk scores to learn if there is an association with the 30 day post&#xD;
      hospital discharge readmission rate post pharmacist intervention. The outcomes will not be&#xD;
      generalizable and will be reported back to the hospital client to demonstrate value added.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 7, 2020</start_date>
  <completion_date type="Anticipated">April 24, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 24, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Readmission</measure>
    <time_frame>2018 - 2019</time_frame>
    <description>Readmission within 30-days post hospital discharge</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hospitalism</condition>
  <arm_group>
    <arm_group_label>Readmitted</arm_group_label>
    <description>Patients that were readmitted within 30 days post hospital discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not readmitted</arm_group_label>
    <description>Patients that were not readmitted within 30 days post hospital discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharmacist transition of care consultation</intervention_name>
    <description>Pharmacist-delivered comprehensive medication review</description>
    <arm_group_label>Not readmitted</arm_group_label>
    <arm_group_label>Readmitted</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Information will be collected from an internal data collection excel used to provide&#xD;
        monthly outcome intervention reports to the local Tucson hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Those referred to receive transition of care services between January 2018 to December&#xD;
             2019 and were discharged on 10 or more medications.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  89 years or older&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Bingham, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tabula Rasa HealthCare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tabula Rasa HealthCare</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 24, 2020</study_first_submitted>
  <study_first_submitted_qc>April 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tabula Rasa HealthCare</investigator_affiliation>
    <investigator_full_name>Jenny Bingham</investigator_full_name>
    <investigator_title>Director, Ambulatory Care Residency Programs &amp; Research</investigator_title>
  </responsible_party>
  <keyword>LACE</keyword>
  <keyword>medication risk score</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

